Concepts (88)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hypertension, Pulmonary | 5 | 2024 | 1580 | 1.580 |
Why?
|
Radiation Pneumonitis | 3 | 2016 | 102 | 1.080 |
Why?
|
Radiosurgery | 6 | 2017 | 1342 | 1.020 |
Why?
|
Idiopathic Interstitial Pneumonias | 1 | 2024 | 24 | 0.930 |
Why?
|
Prostaglandins I | 1 | 2020 | 13 | 0.730 |
Why?
|
Phosphodiesterase 5 Inhibitors | 1 | 2020 | 103 | 0.670 |
Why?
|
Mediastinum | 1 | 2021 | 267 | 0.670 |
Why?
|
Pulmonary Artery | 3 | 2024 | 1938 | 0.640 |
Why?
|
Telangiectasia, Hereditary Hemorrhagic | 1 | 2019 | 141 | 0.550 |
Why?
|
Esophagitis | 1 | 2017 | 164 | 0.530 |
Why?
|
Pulmonary Embolism | 4 | 2024 | 2566 | 0.500 |
Why?
|
Probability | 1 | 2018 | 2478 | 0.420 |
Why?
|
Vascular Diseases | 1 | 2021 | 1161 | 0.400 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 2 | 2024 | 3204 | 0.400 |
Why?
|
Lung Neoplasms | 6 | 2017 | 13337 | 0.360 |
Why?
|
Lung Diseases | 1 | 2021 | 1909 | 0.360 |
Why?
|
Radiation Injuries | 1 | 2017 | 1189 | 0.340 |
Why?
|
Hospitalization | 2 | 2019 | 10718 | 0.330 |
Why?
|
Venous Thrombosis | 1 | 2018 | 1303 | 0.320 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2015 | 1517 | 0.310 |
Why?
|
Hospital Mortality | 2 | 2019 | 5291 | 0.300 |
Why?
|
Heart | 1 | 2021 | 4405 | 0.290 |
Why?
|
Radiotherapy Dosage | 5 | 2017 | 2898 | 0.290 |
Why?
|
Heart Diseases | 1 | 2019 | 2785 | 0.270 |
Why?
|
Diagnostic Imaging | 1 | 2021 | 3530 | 0.270 |
Why?
|
Hemorrhage | 1 | 2018 | 3425 | 0.270 |
Why?
|
Lung | 2 | 2024 | 9995 | 0.260 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 4 | 2016 | 5302 | 0.240 |
Why?
|
Lung Diseases, Interstitial | 2 | 2024 | 917 | 0.220 |
Why?
|
Tomography, X-Ray Computed | 2 | 2024 | 20556 | 0.220 |
Why?
|
Pulmonary Wedge Pressure | 1 | 2024 | 273 | 0.210 |
Why?
|
Epoprostenol | 1 | 2020 | 246 | 0.170 |
Why?
|
Exercise Tolerance | 1 | 2024 | 836 | 0.160 |
Why?
|
Aged | 13 | 2024 | 169235 | 0.150 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2021 | 628 | 0.130 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2017 | 882 | 0.130 |
Why?
|
Lung Volume Measurements | 1 | 2016 | 375 | 0.120 |
Why?
|
Hemodynamics | 1 | 2024 | 4168 | 0.110 |
Why?
|
Tumor Burden | 2 | 2016 | 1890 | 0.110 |
Why?
|
Humans | 18 | 2024 | 761423 | 0.100 |
Why?
|
Retrospective Studies | 8 | 2024 | 80582 | 0.090 |
Why?
|
Antihypertensive Agents | 1 | 2020 | 2023 | 0.090 |
Why?
|
Male | 12 | 2024 | 360736 | 0.090 |
Why?
|
Female | 12 | 2024 | 392581 | 0.080 |
Why?
|
Heart Ventricles | 1 | 2021 | 3816 | 0.080 |
Why?
|
Cost of Illness | 1 | 2019 | 1936 | 0.080 |
Why?
|
Middle Aged | 8 | 2024 | 220826 | 0.080 |
Why?
|
Blood Pressure | 1 | 2024 | 8487 | 0.080 |
Why?
|
Risk | 1 | 2019 | 9612 | 0.070 |
Why?
|
Inpatients | 1 | 2019 | 2548 | 0.070 |
Why?
|
Risk Assessment | 3 | 2024 | 23990 | 0.070 |
Why?
|
Sepsis | 1 | 2019 | 2585 | 0.060 |
Why?
|
Venous Thromboembolism | 1 | 2018 | 1866 | 0.060 |
Why?
|
Severity of Illness Index | 2 | 2021 | 15838 | 0.060 |
Why?
|
Follow-Up Studies | 4 | 2021 | 39117 | 0.060 |
Why?
|
Comorbidity | 1 | 2019 | 10498 | 0.060 |
Why?
|
Neoplasm Staging | 2 | 2016 | 11106 | 0.060 |
Why?
|
Odds Ratio | 1 | 2016 | 9645 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2020 | 10203 | 0.050 |
Why?
|
Multivariate Analysis | 1 | 2016 | 12058 | 0.050 |
Why?
|
Time Factors | 2 | 2024 | 39975 | 0.050 |
Why?
|
Acute Disease | 2 | 2024 | 7238 | 0.050 |
Why?
|
Cohort Studies | 1 | 2024 | 41446 | 0.050 |
Why?
|
Prevalence | 1 | 2019 | 15717 | 0.050 |
Why?
|
Risk Factors | 3 | 2024 | 74167 | 0.050 |
Why?
|
Logistic Models | 1 | 2016 | 13255 | 0.050 |
Why?
|
United States | 4 | 2024 | 72339 | 0.040 |
Why?
|
Prognosis | 2 | 2021 | 29620 | 0.040 |
Why?
|
Cross-Sectional Studies | 1 | 2019 | 26112 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2015 | 9277 | 0.030 |
Why?
|
Respiratory Function Tests | 1 | 2021 | 1682 | 0.030 |
Why?
|
Adult | 4 | 2024 | 221148 | 0.030 |
Why?
|
Survival | 1 | 2016 | 161 | 0.030 |
Why?
|
Pulmonary Veins | 1 | 2021 | 746 | 0.030 |
Why?
|
Relative Biological Effectiveness | 1 | 2016 | 312 | 0.030 |
Why?
|
Survival Rate | 2 | 2021 | 12720 | 0.030 |
Why?
|
Four-Dimensional Computed Tomography | 1 | 2015 | 141 | 0.030 |
Why?
|
Prospective Studies | 1 | 2015 | 54415 | 0.020 |
Why?
|
Echocardiography | 1 | 2021 | 4991 | 0.020 |
Why?
|
Propensity Score | 1 | 2016 | 1908 | 0.020 |
Why?
|
Dyspnea | 1 | 2015 | 1347 | 0.020 |
Why?
|
Linear Models | 1 | 2016 | 5869 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2016 | 6479 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2024 | 58956 | 0.020 |
Why?
|
Survival Analysis | 1 | 2016 | 10089 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2016 | 12456 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2016 | 14664 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2016 | 64651 | 0.010 |
Why?
|
Concepts
(88)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(15)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_